Liu Shao, Luo Ping, Tang Mimi, Hu Qin, Polidoro Joseph P, Sun Shusen, Gong Zhicheng
Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
The Hunan Institute of Pharmacy Practice and Clinical Research, Changsha, 410008, Hunan, China.
Int J Clin Pharm. 2020 Apr;42(2):299-304. doi: 10.1007/s11096-020-01017-0. Epub 2020 Mar 28.
The coronavirus disease 19 (COVID-19) is quickly spreading across China and globally. Pharmacy services are an important pillar in public health to prevent and contain the COVID-19 pandemic. Chinese pharmacists have acted swiftly in the public health response in China, such as drafting professional service guidance to pharmacists and pharmacies, establishing emergency drug formularies, monitoring and resolving drug shortages, establishing remote pharmacy services to prevent human-to-human infections, providing event-driven pharmaceutical care, educating the public on infection prevention and disease management, and participating in clinical trials and drug evaluation. This commentary reviews the unique needs of pharmacy services in the COVID-19 pandemic, and shares our experiences with the international pharmacy community in the response to these needs.
新型冠状病毒肺炎(COVID-19)正在中国和全球迅速蔓延。药学服务是预防和控制COVID-19大流行的公共卫生的重要支柱。中国药师在中国的公共卫生应对中迅速行动,例如起草针对药师和药房的专业服务指南、建立应急药品目录、监测和解决药品短缺问题、建立远程药学服务以防止人际感染、提供事件驱动型药学服务、对公众进行感染预防和疾病管理教育,以及参与临床试验和药物评价。本述评回顾了COVID-19大流行中药学服务的独特需求,并与国际药学界分享我们应对这些需求的经验。